The Valley Desk

Clinical trial reportArthritis & rheumatology (Hoboken, N.J.)Published

Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept Study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Arthritis & rheumatology (Hoboken, N.J.)
Published
Subject terms
Humans; Arthritis, Psoriatic; C-Reactive Protein; Antirheumatic Agents; Antibodies, Monoclonal; Treatment Outcome; Drug Therapy, Combination; Injections, Subcutaneous; Double-Blind Method; Adult; Middle Aged; Female
PubMed ID
41878957
PubMed Central ID
PMC13712541
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal